Chemical Compound

Gypenoside XIII

CAS Registry Number 80325-22-0
Gypenoside XIII chemical structure
Primary Record

Gypenoside XIII

Note: Only for scientific research or as raw materials for production.

In stock
9,209 g
Purity
99.1 %
CAS
80325-22-0

Compound Identifiers & Properties

CAS
80325-22-0
PubChem CID
11331683
SMILES
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)O)O)O)C
Canonical SMILES
CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO[C@@H]2OC[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3CC[C@]12C

Names & Synonyms

  • Gypenoside XIII
  • ginsenoside Mx
  • Gisenoside C-Mx
  • RefChem:143216
  • 80325-22-0
  • CHEBI:77490
  • orb1707937
  • SCHEMBL29696365
  • FDA32522
  • HY-N6881
  • AKOS040740805
  • CID11331683
  • DA-53799
  • MS-31334
  • CS-0100475
  • J2.134.465F
  • G16938
  • A1038454
  • Q27147037
  • (2S,3R,4S,5S,6R)-2-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol
  • 20-[beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranosyloxy]dammar-24-ene-3beta,12-diol
  • (3beta,12beta)-3,12-dihydroxydammar-24-en-20-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
  • 20-(beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranosyloxy)dammar-24-ene-3beta,12-diol
  • 20-[6-O-(beta-D-Xylopyranosyl)-beta-D-glucopyranosyloxy]dammara-24-ene-3beta,12beta-diol
  • (2S,3R,4S,5S,6R)-2-(((S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy)-6-((((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-((2S)-2-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-methylhept-5-en-2-yl)oxy-6-(((2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl)oxymethyl)oxane-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5aR,7S,9aR,9bR,11R,11aR)-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
  • 20-(6-O-beta-D-Xylopyranosyl-beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta-diol
  • 3beta,12beta-Dihydroxy-5alpha-dammara-24-ene-20-yl 6-O-(beta-D-xylopyranosyl)-beta-D-glucopyranoside